STOCK-BASED COMPENSATION (Tables)

9 Months Ended

Jul. 28, 2019

Disclosure of Compensation Related Costs, Share-based Payments [Abstract]

Schedule of reconciliation of the number of options outstanding and exercisable

A reconciliation of the number of options outstanding and exercisable (in thousands) as of July 28, 2019, and changes during the nine months then ended, is as follows:

	Shares	Weighted- Average Exercise Price		Weighted- Average Remaining Contractual Term (Years)	Aggregate Intrinsic Value
Outstanding at October 28, 2018	29,536	$	23.55
Granted	1,809	44.37
Exercised	3,790	12.70
Forfeited	660	36.37
Expired	5	35.87
Outstanding at July 28, 2019	26,890	26.16		5.3	$	414,544
Exercisable at July 28, 2019	18,763	$	21.09	4.0	$	380,708

Schedule of weighted-average grant date fair value of stock options granted and the total intrinsic value of options exercised

The weighted-average grant date fair value of stock options granted and the total intrinsic value of options exercised (in thousands) during the third quarter and first nine months of fiscal years 2019 and 2018, are as follows. There were no stock options granted during the third quarter of fiscal year 2019.

	Three Months Ended				Nine Months Ended
	July 28, 2019		July 29, 2018		July 28, 2019		July 29, 2018
Weighted-average grant date fair value	$	—	$	7.33	$	9.24	$	7.16
Intrinsic value of exercised options	$	7,308	$	25,136	$	115,094	$	96,950

Schedule of weighted-average assumptions used to calculate fair value of each option award

The fair value of each option award is calculated on the date of grant using the Black-Scholes valuation model utilizing the following weighted-average assumptions:

0.029	Three Months Ended			Nine Months Ended
	July 28, 2019	July 29, 2018		July 28, 2019		July 29, 2018
Risk-free interest rate	—	2.9	%	2.8	%	2.7	%
Dividend yield	—	2.1	%	1.9	%	2.1	%
Stock price volatility	—	19.0	%	19.0	%	19.0	%
Expected option life	—	8 years		8 years		8 years

Schedule of reconciliation of the nonvested shares

A reconciliation of the restricted shares (in thousands) as of July 28, 2019, and changes during the nine months then ended, is as follows:

	Shares	Weighted- Average Grant Date Fair Value
Restricted at October 28, 2018	52	$	34.08
Granted	51	42.23
Vested	52	34.08
Restricted at July 28, 2019	51	$	42.23

Schedule of the weighted-average grant date fair value of nonvested shares granted, the total fair value of nonvested shares granted, and the fair value of shares that have vested

The weighted-average grant date fair value of restricted shares granted, the total fair value (in thousands) of restricted shares granted, and the fair value (in thousands) of shares that have vested during the first nine months of fiscal years 2019 and 2018, are as follows:

	Nine Months Ended
	July 28, 2019		July 29, 2018
Weighted-average grant date fair value	$	42.23	$	34.08
Fair value of restricted shares granted	2,134		1,760
Fair value of shares vested	1,760		2,053